Publications by authors named "John J V McMurray"

100Publications

Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.

JACC Heart Fail 2020 Nov 4. Epub 2020 Nov 4.

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2020.08.014DOI Listing
November 2020

Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.

Circulation 2020 Nov 13. Epub 2020 Nov 13.

The George Institute for Global Health, Sydney, Australia; Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.051675DOI Listing
November 2020

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

N Engl J Med 2020 Nov 13. Epub 2020 Nov 13.

From the Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco (J.R.T.), Amgen, Thousand Oaks (L.S., J.C.L., N.H., S.A.A., C.E.K.), and Cytokinetics, South San Francisco (F.I.M.) - all in California; Estudios Clínicos Latino América, Rosario, Argentina (R.D.); the Division of Cardiology, Duke University School of Medicine and Duke Clinical Research Institute, Durham (G.M.F.), and the University of North Carolina, Chapel Hill (K.F.A.) - both in North Carolina; the British Heart Foundation Cardiovascular Research Centre (J.J.V.M.) and the Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College, London (J.G.F.C.) - both in the United Kingdom; Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiologic Sciences, and Public Health, University of Brescia, Brescia, Italy (M.M.); the Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (S.D.S.); the University of Minnesota, Minneapolis (I.A.); Instituto Nacional de Cardiología, Mexico City (A.A.-M.); the Department of Cardiology, Herlev and Gentofte Hospital, and the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen (T.B.-S.); Saarland University, Universitätsklinikum des Saarlandes, Homburg, Germany (M.B.); Medical University of Vienna, Vienna (D.B.); Pontificia Universidad Católica de Chile, Santiago (R.C.); Complexo Hospitalario Universitario A Coruña, Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares, Instituto de Investigación Biomédica de A Coruña, Universidade da Coruña, A Coruña, Spain (M.G.C.-L.); the Departments of Cardiology and Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden (U.D.); Fundación Cardiovascular de Colombia, Floridablanca, Colombia (L.E.E.); University of Utah, Salt Lake City (J.C.F.); National and Kapodistrian University of Athens, Attikon University Hospital, Athens (G.F.); Hospital S. Francisco Xavier, Centro Hospitalar Lisboa Ocidental, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal (C.F.); Commenius University, Bratislava, Slovakia (E.G.); the Department of Cardiology, Queen Giovanna University Hospital and Medical University, Sofia, Bulgaria (A.R.G.); Libin Cardiovascular Institute and Cumming School of Medicine, University of Calgary, Calgary, AB (J.G.H.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Heart and Vascular Institute, Henry Ford Hospital, Detroit (D.E.L.); the National Clinical Research Center for Cardiovascular Diseases, National Health Commission Key Laboratory of Clinical Research for Cardiovascular Medications, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.L.); Middlemore Hospital, Otahuhu, Auckland, New Zealand (M.L.); St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia (P.M.); University Clinic of Lomonosov, Moscow State University, Moscow (V.M.); Saitama Citizens Medical Center, Saitama, Japan (S.M.); Institute of Cardiology, Kyiv, Ukraine (A.P.); Wroclaw Medical University, Wroclaw, Poland (P.P.); Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo (F.J.A.R.); Vilnius University, Vilnius, Lithuania (P.S.); the University of Cape Town, Cape Town, South Africa (K.S.); the Internal Cardiology Department, St. Ann Hospital and Masaryk University Brno, Brno, Czech Republic (J.S.); the Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (T.M.S.); St. John of God Hospital, Budapest, Hungary (J.T.); AZ Sint-Lucas, Ghent, Belgium (H.V.); the University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania (D.V.); the University of Groningen, Groningen, the Netherlands (A.A.V.); Dokuz Eylul University, Izmir, Turkey (M.B.Y.); and Université de Lorraine, INSERM Investigation Network Initiative Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional Universitaire de Nancy, Nancy (F.Z.), and Servier, Suresnes (C.V.) - both in France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2025797DOI Listing
November 2020

Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients with Chronic Heart Failure: Results from the COSMIC-HF Study.

Circ Heart Fail 2020 Nov 12. Epub 2020 Nov 12.

Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007814DOI Listing
November 2020

Ultrasound imaging of congestion in heart failure - Examinations beyond the heart.

Eur J Heart Fail 2020 Oct 29. Epub 2020 Oct 29.

Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, INSERM 1433, CHRU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Nancy, France, and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.2032DOI Listing
October 2020

Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF.

ESC Heart Fail 2020 Oct 19. Epub 2020 Oct 19.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12972DOI Listing
October 2020

Estimating the Lifetime Benefits of Treatments for Heart Failure.

JACC Heart Fail 2020 Oct 2. Epub 2020 Oct 2.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2020.08.004DOI Listing
October 2020

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial.

Diabetes Res Clin Pract 2020 Oct 6;170:108488. Epub 2020 Oct 6.

Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2020.108488DOI Listing
October 2020

Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF.

JACC Heart Fail 2020 Oct;8(10):800-810

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2020.06.020DOI Listing
October 2020

Dapagliflozin in Patients with Chronic Kidney Disease.

N Engl J Med 2020 10 24;383(15):1436-1446. Epub 2020 Sep 24.

From the Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the George Institute for Global Health, Sydney (H.J.L.H., D.C.W.); Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (B.V.S., M.L., C.D.S., A.-M.L.); the National Medical Science and Nutrition Institute Salvador Zubirán, Mexico City (R.C.-R.); the Departments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA (G.M.C.); the Study Design and Biostatistics Center, University of Utah Health Sciences, Salt Lake City (T.G.); the Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, Guangzhou, China (F.-F.H.); KfH Kidney Center, Munich, and Department of Medicine 4, University of Erlangen-Nuremberg, Erlangen - both in Germany (J.F.E.M.); the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow (J.J.V.M.), and the Department of Renal Medicine, University College London, London (D.C.W.) - both in the United Kingdom; Steno Diabetes Center Copenhagen, Gentofte, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen - both in Denmark (P.R.); and the Department of Internal Medicine, UT Southwestern Medical Center, Dallas (R.D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2024816DOI Listing
October 2020

EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.

Eur J Heart Fail 2020 Sep 18. Epub 2020 Sep 18.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.2006DOI Listing
September 2020

Serum potassium in the PARADIGM-HF trial.

Eur J Heart Fail 2020 Aug 18. Epub 2020 Aug 18.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1987DOI Listing
August 2020

Angiotensin receptor-neprilysin inhibition in heart failure with preserved ejection fraction: lessons from PARAGON-HF.

Eur J Heart Fail 2020 Sep 28;22(9):1525-1530. Epub 2020 Aug 28.

Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1976DOI Listing
September 2020

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.

J Am Coll Cardiol 2020 Aug;76(5):503-514

Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina; Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.05.072DOI Listing
August 2020

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial.

JACC Heart Fail 2020 Oct 8;8(10):811-818. Epub 2020 Jul 8.

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2020.04.008DOI Listing
October 2020

Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF".

Circulation 2020 Jul 6;142(1):e5-e6. Epub 2020 Jul 6.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (A.M.J., P.S.J., J.J.V.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047275DOI Listing
July 2020

Do We Need Clinical Events Committees to Adjudicate End Points?

Circ Heart Fail 2020 07 25;13(7):e007209. Epub 2020 Jun 25.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Scotland, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007209DOI Listing
July 2020

Use of the Win Ratio in Cardiovascular Trials.

JACC Heart Fail 2020 06;8(6):441-450

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2020.02.010DOI Listing
June 2020

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure.

ESC Heart Fail 2020 08 8;7(4):1595-1604. Epub 2020 May 8.

Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373887PMC
August 2020

VICTORIA in context.

Eur J Heart Fail 2020 May 3. Epub 2020 May 3.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1833DOI Listing
May 2020

Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.

Circulation 2020 07 22;142(1):4-6. Epub 2020 Apr 22.

Institute of Cardiovascular and Medical Sciences (N.S., J.J.V.M.), University of Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047659DOI Listing
July 2020

Chagas disease: still a neglected emergency?

Lancet 2020 04;395(10230):1113-1114

Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)30171-9DOI Listing
April 2020

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

N Engl J Med 2020 04 30;382(17):1653-1659. Epub 2020 Mar 30.

From the Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston (M.V., T.M., M.A.P., S.D.S.); the Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, and University of Minnesota, Minneapolis (O.V.); and the British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (J.J.V.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsr2005760DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121452PMC
April 2020

Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction.

Eur Heart J 2020 Jul;41(25):2353-2355

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa158DOI Listing
July 2020

Covariate adjusted reanalysis of the I-Preserve trial.

Clin Res Cardiol 2020 Nov 25;109(11):1358-1365. Epub 2020 Mar 25.

BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-020-01632-xDOI Listing
November 2020

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.

J Am Coll Cardiol 2020 Apr 16;75(14):1644-1656. Epub 2020 Mar 16.

Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.02.009DOI Listing
April 2020

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply.

N Engl J Med 2020 03;382(12):1182-1183

University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2000284DOI Listing
March 2020

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.

N Engl J Med 2020 03;382(10):973

University of Glasgow, Glasgow, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1917241DOI Listing
March 2020

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure.

Eur J Heart Fail 2020 May 2;22(5):898-901. Epub 2020 Mar 2.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1776DOI Listing
May 2020

Diagnosing heart failure with preserved ejection fraction - what's the score?

Eur J Heart Fail 2020 03 22;22(3):425-427. Epub 2020 Feb 22.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1764DOI Listing
March 2020

Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure.

ESC Heart Fail 2020 06 20;7(3):1201-1209. Epub 2020 Feb 20.

Department of Emergency Medicine, Brigham and Women's Hospital, 75 Francis Street, Neville House, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261588PMC
June 2020

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials.

Eur J Heart Fail 2020 May 19;22(5):834-844. Epub 2020 Feb 19.

Centre d'Investigation Clinique-Plurithématique INSERM CIC-P 1433, and INSERM U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1740DOI Listing
May 2020

Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.

Circ Heart Fail 2020 02 17;13(2):e006541. Epub 2020 Feb 17.

BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.R., P.S.J., S.L.K., P.W., J.J.V.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006541DOI Listing
February 2020

How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials.

Arterioscler Thromb Vasc Biol 2020 03 30;40(3):506-522. Epub 2020 Jan 30.

From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.119.311904DOI Listing
March 2020

β-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications.

Circ Heart Fail 2020 01 20;13(1):e006155. Epub 2020 Jan 20.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (J.J.V.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006155DOI Listing
January 2020

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.

JACC Heart Fail 2020 03 8;8(3):188-198. Epub 2020 Jan 8.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086149PMC
March 2020

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure.

Authors:
Sonia Shah Albert Henry Carolina Roselli Honghuang Lin Garðar Sveinbjörnsson Ghazaleh Fatemifar Åsa K Hedman Jemma B Wilk Michael P Morley Mark D Chaffin Anna Helgadottir Niek Verweij Abbas Dehghan Peter Almgren Charlotte Andersson Krishna G Aragam Johan Ärnlöv Joshua D Backman Mary L Biggs Heather L Bloom Jeffrey Brandimarto Michael R Brown Leonard Buckbinder David J Carey Daniel I Chasman Xing Chen Xu Chen Jonathan Chung William Chutkow James P Cook Graciela E Delgado Spiros Denaxas Alexander S Doney Marcus Dörr Samuel C Dudley Michael E Dunn Gunnar Engström Tõnu Esko Stephan B Felix Chris Finan Ian Ford Mohsen Ghanbari Sahar Ghasemi Vilmantas Giedraitis Franco Giulianini John S Gottdiener Stefan Gross Daníel F Guðbjartsson Rebecca Gutmann Christopher M Haggerty Pim van der Harst Craig L Hyde Erik Ingelsson J Wouter Jukema Maryam Kavousi Kay-Tee Khaw Marcus E Kleber Lars Køber Andrea Koekemoer Claudia Langenberg Lars Lind Cecilia M Lindgren Barry London Luca A Lotta Ruth C Lovering Jian'an Luan Patrik Magnusson Anubha Mahajan Kenneth B Margulies Winfried März Olle Melander Ify R Mordi Thomas Morgan Andrew D Morris Andrew P Morris Alanna C Morrison Michael W Nagle Christopher P Nelson Alexander Niessner Teemu Niiranen Michelle L O'Donoghue Anjali T Owens Colin N A Palmer Helen M Parry Markus Perola Eliana Portilla-Fernandez Bruce M Psaty Kenneth M Rice Paul M Ridker Simon P R Romaine Jerome I Rotter Perttu Salo Veikko Salomaa Jessica van Setten Alaa A Shalaby Diane T Smelser Nicholas L Smith Steen Stender David J Stott Per Svensson Mari-Liis Tammesoo Kent D Taylor Maris Teder-Laving Alexander Teumer Guðmundur Thorgeirsson Unnur Thorsteinsdottir Christian Torp-Pedersen Stella Trompet Benoit Tyl Andre G Uitterlinden Abirami Veluchamy Uwe Völker Adriaan A Voors Xiaosong Wang Nicholas J Wareham Dawn Waterworth Peter E Weeke Raul Weiss Kerri L Wiggins Heming Xing Laura M Yerges-Armstrong Bing Yu Faiez Zannad Jing Hua Zhao Harry Hemingway Nilesh J Samani John J V McMurray Jian Yang Peter M Visscher Christopher Newton-Cheh Anders Malarstig Hilma Holm Steven A Lubitz Naveed Sattar Michael V Holmes Thomas P Cappola Folkert W Asselbergs Aroon D Hingorani Karoline Kuchenbaecker Patrick T Ellinor Chim C Lang Kari Stefansson J Gustav Smith Ramachandran S Vasan Daniel I Swerdlow R Thomas Lumbers

Nat Commun 2020 01 9;11(1):163. Epub 2020 Jan 9.

British Heart Foundation Research Accelerator, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-13690-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952380PMC
January 2020

The year in cardiology: heart failure.

Eur Heart J 2020 Mar;41(12):1232-1248

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084174PMC
March 2020

The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.

Eur Heart J 2020 Jan 3. Epub 2020 Jan 3.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz916DOI Listing
January 2020

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCAT.

JACC Heart Fail 2019 12;7(12):1012-1021

Université de Lorraine, Centre d'Investigation Clinique-Plurithématique INSERM 1433, and Cardiovascular and Renal Clinical Trialists, INSERM U1116, CHRU Nancy Brabois, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.017DOI Listing
December 2019

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF.

J Am Coll Cardiol 2020 01 11;75(3):245-254. Epub 2019 Nov 11.

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.11.003DOI Listing
January 2020

Income level and inequality as complement to geographical differences in cardiovascular trials.

Am Heart J 2019 12 1;218:66-74. Epub 2019 Sep 1.

Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.08.019DOI Listing
December 2019

Lung ultrasound: monitoring congestion in patients with heart failure.

Eur J Heart Fail 2019 12 8;21(12):1614-1615. Epub 2019 Nov 8.

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644141PMC
December 2019

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial.

J Hypertens 2020 03;38(3):420-425

Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002275DOI Listing
March 2020

Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes.

JACC Heart Fail 2019 10;7(10):849-858

British Heart Foundation (BHF) Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.07.008DOI Listing
October 2019